华仁药业
(300110)
| 流通市值：38.03亿 | | | 总市值：38.07亿 |
| 流通股本：11.81亿 | | | 总股本：11.82亿 |
| 报告期 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 181,984,201.47 | 163,813,254.9 | 120,100,595.17 | 114,513,328.29 |
| 应收票据及应收账款 | 537,471,940.05 | 529,961,276.84 | 584,555,110.68 | 612,478,471.99 |
| 其中：应收票据 | 10,281,791.52 | 3,550,592.27 | 989,058.59 | 1,402,767.24 |
| 应收账款 | 527,190,148.53 | 526,410,684.57 | 583,566,052.09 | 611,075,704.75 |
| 应收款项融资 | 69,622,083.25 | 98,485,665.29 | 86,246,628.64 | 139,087,746.51 |
| 预付款项 | 31,208,317.51 | 20,286,124.35 | 47,526,886.2 | 59,829,301.28 |
| 其他应收款合计 | 45,027,438.34 | 34,706,613.75 | 1,369,964,879.32 | 1,369,643,512.53 |
| 存货 | 281,481,226.88 | 318,237,397.12 | 310,685,070.75 | 319,066,378.12 |
| 其他流动资产 | 23,125,808.13 | 19,488,277.34 | 19,721,985.64 | 15,067,917.96 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 1,169,921,015.63 | 1,184,978,609.59 | 2,538,801,156.4 | 2,629,686,656.68 |
| 非流动资产: | | | | |
| 其他权益工具投资 | 15,984,624 | 15,984,624 | 15,984,624 | 15,984,624 |
| 投资性房地产 | 9,027,891.48 | 9,099,952.02 | 9,172,012.56 | 9,244,073.1 |
| 固定资产 | 1,013,026,006.03 | 1,013,876,010.17 | 1,020,323,150.12 | 1,038,968,307.38 |
| 在建工程 | 85,119,270.14 | 61,897,249 | 58,092,354.39 | 49,534,828.6 |
| 使用权资产 | 174,211.32 | 278,738.12 | 383,264.91 | 487,791.71 |
| 无形资产 | 301,660,877.4 | 301,702,760.5 | 307,728,313.87 | 310,503,473.11 |
| 开发支出 | 6,160,665.71 | 5,924,582.31 | 8,729,000.53 | 11,646,892.13 |
| 商誉 | 732,611,620.38 | 732,611,620.38 | 820,041,620.38 | 820,041,620.38 |
| 长期待摊费用 | 9,296,479.5 | 12,203,059.98 | 12,866,424.14 | 11,428,831.78 |
| 递延所得税资产 | 57,223,085.87 | 57,186,729.9 | 42,479,742.8 | 43,178,293 |
| 其他非流动资产 | 49,958,386.92 | 32,376,143.42 | 38,059,791.14 | 38,197,225.14 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 2,280,243,118.75 | 2,243,141,469.8 | 2,333,860,298.84 | 2,349,215,960.33 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 3,450,164,134.38 | 3,428,120,079.39 | 4,872,661,455.24 | 4,978,902,617.01 |
| 流动负债: | | | | |
| 短期借款 | 488,973,603.47 | 424,409,222.57 | 420,057,165.11 | 415,994,244.6 |
| 应付票据及应付账款 | 121,898,794.15 | 147,354,912.89 | 114,143,912.22 | 154,051,749.14 |
| 应付账款 | 121,898,794.15 | 147,354,912.89 | 114,143,912.22 | 154,051,749.14 |
| 合同负债 | 29,739,775.81 | 32,463,991.71 | 36,759,421.8 | 35,363,498.63 |
| 应付职工薪酬 | 21,240,645.5 | 17,055,717.7 | 15,674,346.65 | 14,971,379.27 |
| 应交税费 | 22,034,331.04 | 21,201,790.71 | 18,156,091.71 | 21,137,684.17 |
| 其他应付款合计 | 210,507,212.71 | 208,241,812.09 | 209,840,315.5 | 234,826,258.67 |
| 一年内到期的非流动负债 | 725,885,124.8 | 692,952,562.4 | 604,726,128 | 633,770,064.7 |
| 其他流动负债 | 3,866,170.85 | 2,951,861.98 | 4,778,724.83 | 4,597,254.82 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 1,624,145,658.33 | 1,546,631,872.05 | 1,424,136,105.82 | 1,514,712,134 |
| 非流动负债: | | | | |
| 长期借款 | 392,825,250 | 464,080,000 | 566,680,000 | 605,340,000 |
| 租赁负债 | - | - | 0 | 0 |
| 递延收益 | 131,559.37 | 131,559.37 | 175,412.49 | 175,412.49 |
| 递延所得税负债 | 42,586,698.29 | 43,348,308.62 | 44,438,299.55 | 45,199,909.88 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 435,543,507.66 | 507,559,867.99 | 611,293,712.04 | 650,715,322.37 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 2,059,689,165.99 | 2,054,191,740.04 | 2,035,429,817.86 | 2,165,427,456.37 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 1,182,212,982 | 1,182,212,982 | 1,182,212,982 | 1,182,212,982 |
| 资本公积 | 528,044,115.47 | 528,044,115.47 | 528,044,115.47 | 528,044,115.47 |
| 盈余公积 | 90,528,384.95 | 90,528,384.95 | 84,617,614.5 | 84,617,614.5 |
| 未分配利润 | -483,970,743.77 | -499,999,193.41 | 969,921,499.96 | 947,603,591.33 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 1,316,814,738.65 | 1,300,786,289.01 | 2,764,796,211.93 | 2,742,478,303.3 |
| 少数股东权益 | 73,660,229.74 | 73,142,050.34 | 72,435,425.45 | 70,996,857.34 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 1,390,474,968.39 | 1,373,928,339.35 | 2,837,231,637.38 | 2,813,475,160.64 |
| 负债和股东权益合计 | 3,450,164,134.38 | 3,428,120,079.39 | 4,872,661,455.24 | 4,978,902,617.01 |
| 公告日期 | 2025-04-23 | 2025-04-23 | 2024-10-29 | 2024-08-30 |
| 审计意见(境内) | | 标准无保留意见 | | |